| Business Summary | | Bio-Imaging
Technologies,
Inc.
is
a
pharmaceutical
contract
service
organization,
providing
services
that
support
the
product
development
process
of
the
pharmaceutical,
biotechnology
and
medical
device
industries.
The
Company
specializes
in
assisting
its
clients
in
the
design
and
management
of
the
medical-imaging
component
of
clinical
trials
for
all
modalities
that
consist
of
computerized
tomography
(CT),
magnetic
resonance
imaging
(MRI),
x-rays,
dual
energy
x-ray
absorptiometry
(DEXA),
position
emission
tomography
single
photon
emission
computerized
tomography
(PET
SPECT)
and
ultrasound. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | BITI
provides
medical
imaging
management
services,
such
as
data
collection,
processing,
analysis
and
archival
services,
for
clinical
development
purposes
through
its
core
lab
facilities
in
the
U.S.
and
Europe.
For
the
nine
months
ended
6/01,
revenues
rose
50%
to
$6.2
million.
Net
income
applicable
to
Common
totalled
$342
thousand
vs.
a
loss
of
$787
thousand.
Revenues
reflect
an
increase
in
clients
and
active
projects.
Net
income
also
reflects
improved
operating
efficiencies. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| David Nowicki, 48 Chairman | -- | Mark Weinstein, 47 Pres,
CEO, Chief Financial Officer, Director | $190K | David Pitler, 45 VP-Operations | 67K | Andrew Reiter, 46 VP
and Managing Director of Bio-Imaging Technologies B.V. | 164K | Colin Miller, Ph.D., 40 VP-Bus.
Devel. | 120K | Dollar amounts are as of 30-Sep-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|